Product Description
A cell-permeable, potent, and reversible proteasome inhibitor (Ki = 4 nM). Reduces degradation of ubiquitin-conjugated proteins in mammalian cells and permeable strains of yeast by the 26S complex without affecting its ATPase or isopeptidase activities. Activates c-Jun N-terminal kinase (JNK1), which initiates apoptosis. Inhibits NF-kB activation (IC₅₀ = 3 µM). Prevents γ-secretase cleavage.
MG-132 is a cell-permeable, potent, and reversible proteasome inhibitor (Ki = 4 nM). Reduces degradation of ubiquitin-conjugated proteins in mammalian cells and permeable strains of yeast by the 26S complex without affecting its ATPase or isopeptidase activities.
Biovision | 1703 | MG-132 DataSheet
Alternate Name/Synonyms: Z-Leu-Leu-Leu-CHO; Z-LLL-CHO
Appearance: White to off-white solid
Formulation: N/A
CAS Number: 133407-82-6
Structure Available?: Yes
Peptide sequence: Z-Leu-Leu-Leu-CHO; Z-LLL-CHO
Salt Form: No
Molecular Formula: C₂₆H₄₁N₃O₅
Molecular Weight: 475.6
Cell-Permeable?: Yes
Purity: ≥98% by HPLC
Solubilities: DMSO (10 mg/ml)
Handling: Protect from air and moisture
Country of Origin: USA
Tag Line: A proteasome inhibitor
MDL Number: MFCD00674886
PubChem CID: 462382
SMILES: CC(C)CC(C=O)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)OCC1=CC=CC=C1
InChi: InChI=1S/C26H41N3O5/c1-17(2)12-21(15-30)27-24(31)22(13-18(3)4)28-25(32)23(14-19(5)6)29-26(33)34-16-20-10-8-7-9-11-20/h7-11,15,17-19,21-23H,12-14,16H2,1-6H3,(H,27,31)(H,28,32)(H,29,33)/t21-,22-,23-/m0/s1
InChi Key: TZYWCYJVHRLUCT-VABKMULXSA-N